Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
60 Results for "
amyloid-beta 1-40
" in MedChemExpress (MCE) Product Catalog:
Products (60)
60 Results for "amyloid-beta 1-40" in MCE Product Catalog:
11
11 Publications Verification
Cat. No.: HY-P0265A
Synonyms: amyloid β-Peptide (1-40) (human) TFA; Aβ40 (human) TFA; Aβ(1-40) (human) TFA
Target:
Research Areas:
11
11 Publications Verification
Cat. No.: HY-P0265C
Target:
Research Areas:
2
2 Cited Publications
Synonyms: BIIB067; ISIS-SOD1Rx; ISIS 333611
Target:
Research Areas:
Tofersen (BIIB067) is an antisense oligonucleotide and SOD1 mRNA inhibitor with an IC50 of 320 pM. Tofersen mediates RNase H-dependent degradation of SOD1 mRNA to reduce SOD1 protein levels in cerebrospinal fluid and serum. Tofersen downregulates cerebrospinal fluid neurofilament light chain, neurofilament heavy chain, amyloid-beta 1-40, amyloid-beta 1-42, neuropeptide Y, ubiquitin C-terminal hydrolase L1, neuropentraxins 1, 2, R, corticotropin-releasing hormone, IL-15, and serum neurofilament light chain, neurofilament heavy chain. Tofersen can be used for the research of superoxide dismutase 1-associated amyotrophic lateral sclerosis .
2
2 Cited Publications
Synonyms: BIIB067 sodium; ISIS-SOD1Rx sodium; ISIS 333611 sodium
Target:
Research Areas:
Tofersen (BIIB067) sodium is an antisense oligonucleotide and SOD1 mRNA inhibitor with an IC50 of 320 pM. Tofersen sodium mediates RNase H-dependent degradation of SOD1 mRNA to reduce SOD1 protein levels in cerebrospinal fluid and serum. Tofersen sodium downregulates cerebrospinal fluid neurofilament light chain, neurofilament heavy chain, amyloid-beta 1-40, amyloid-beta 1-42, neuropeptide Y, ubiquitin C-terminal hydrolase L1, neuropentraxins 1, 2, R, corticotropin-releasing hormone, IL-15, and serum neurofilament light chain, neurofilament heavy chain. Tofersen sodium can be used for the research of superoxide dismutase 1-associated amyotrophic lateral sclerosis .
2
2
2 Cited Publications
Cat. No.: HY-P70577
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: SNCA; Parkinson Disease (Autosomal Dominant, Lewy Body) 4; Prev. PARK1; Non-A4 Component Of amyloid Precursor; Prev. PARK4; Non A-beta Component Of AD amyloid; Alpha-Synuclein; Non-A beta Component Of AD amyloid; NACP; Synuclein Alpha-140; PD1; I+/--Synuclein; Synuclein, Alpha (Non A4 Component Of amyloid Precursor); Α-Synuclein; Synuclein Alpha; Non A4 Component Of amyloid Precursor
Species:
Human
Source:
E. coli
1
1 Cited Publications
Cat. No.: HY-P704352
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: APP; PreA4; Prev. AD1; CVAP; Alzheimer Disease amyloid A4 Protein Homolog; beta-amyloid Precursor Protein; amyloid-beta Precursor Protein; Testicular Tissue Protein Li 2; amyloid Precursor Protein; beta-amyloid Peptide(1-40); Alpha-SAPP; beta-amyloid Pept
Species:
Human
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P71327
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: SNCA; Parkinson Disease (Autosomal Dominant, Lewy Body) 4; Prev. PARK1; Non-A4 Component Of amyloid Precursor; Prev. PARK4; Non A-beta Component Of AD amyloid; Alpha-Synuclein; Non-A beta Component Of AD amyloid; NACP; Synuclein Alpha-140; PD1; I+/--Synuc
Species:
Human
Source:
E. coli
Cat. No.: HY-P990109
Target:
Research Areas:
Cat. No.: HY-P10040
Target:
Research Areas:
Cat. No.: HY-P1387
CAS No.: 144409-98-3
Research Areas:
Cat. No.: HY-P2550A
Target:
Research Areas:
Cat. No.: HY-P2550
CAS No.: 1678416-08-4
Target:
Research Areas:
Cat. No.: HY-P2549
CAS No.: 183906-14-1
Target:
Research Areas:
Cat. No.: HY-P0265AS
Synonyms: amyloid beta-Peptide-15N (1-40) (human) TFA; amyloid β-Peptide-15N (1-40) (human) TFA
Target:
Research Areas:
Cat. No.: HY-P10040A
Target:
Research Areas:
Cat. No.: HY-P5906
Synonyms: Citrullinated Aβ (1-40); Citrullinated Aβ40
Target:
Research Areas:
Target:
Research Areas:
(S)-(-)-Anatabine is an NFκB/BACE-1 inhibitor with blood-brain barrier penetration. (S)-(-)-Anatabine inhibits NFκB activation via phosphorylation of its p65 subunit. (S)-(-)-Anatabine inhibits BACE-1 transcription and reduces BACE-1 protein levels. (S)-(-)-Anatabine lowers production of Aβ1-40 and Aβ1-42 by reducing β-cleavage of amyloid precursor protein without affecting α-cleavage. (S)-(-)-Anatabine can be used for the research of Alzheimer's disease .
Cat. No.: HY-P5370
CAS No.: 1678415-68-3
Cat. No.: HY-P4893
CAS No.: 374796-75-5
Target:
Research Areas:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
